Tempus is a Chicago-based company that improves the precision medicine industry through the application of artificial intelligence. Tempus creates a clinical and molecular data library that makes it easy for physicians to access and use. As Eric Lefkofsky explains, through artificial intelligence and machine learning technology, Tempus has enabled physicians to deliver the proper treatment and care for patients ailing from cancer.
Tempus is led and operated by Eric Lefkofsky, the founder and CEO. Mr. Lefkofsky attended the University of Michigan Law School, where he acquired a Juris Doctor in law. After completing his studies, he embarked on his entrepreneurship journey, where he established multiple companies in different diverse sectors. With interest in disruptive technology, Eric Lefkofsky established several companies in the same field including Echo Global Logistics, Mediabank, and Lightbank.
These companies have successfully grown for the last 15 years under the healthcare expert and entrepreneur Eric Lefkofsky’s leadership. Up to now, Mediabank and Lightbank companies are recognized organizations across the US, with several different scattered locations. Tempus is currently hitting the headlines with its movement and efforts in precision medicine, including completing the acquisition of Highline Sciences.
Highline Sciences is an organization with a critical interest in oncology and offers specialized clinical contract research services. With its excellent capabilities in managing and executing clinical trials, Highline Sciences will automatically complement Tempus’ services in growing, establishing, and supporting other businesses in the same line, Eric Lefkofsky finally adds. By acquiring Highline Sciences, Tempus will focus entirely on making a significant positive change in patients’ lives and creating new innovative approaches and ways in providing and improving clinical research services.